My 13 reasons for marijuana use post-stroke.
But don't listen to me, I have absolutely no medical training. And since I'm stroke-addled my reasoning skills are non-existent. I will get some after my next stroke even if I have to travel to one of these states or Uruguay or Netherlands or North Korea and soon Canada.
This animated map shows where marijuana is legal in the US
https://www.mdlinx.com/internal-medicine/medical-news-article/2016/04/26/cannabis-ischemia-marijuana-subarachnoid-hemorrhage/6644704/?
Stroke
Behrouz R, et al.
The objective was to evaluate
the relationship between cannabis use and outcomes in patients with
aneurysmal subarachnoid hemorrhage (aSAH). The authors offer preliminary
data that CB+ is independently associated with delayed cerebral
ischemia and possibly poor outcome in patients with aSAH. The findings
add to the growing evidence on the association of cannabis with
cerebrovascular risk.
Methods
- Records of consecutive patients admitted with aSAH between 2010 and 2015 were reviewed.
- Clinical features and outcomes of aSAH patients with negative urine drug screen and cannabinoids-positive (CB+) were compared.
- Regression analyses were used to assess for associations.
Results
- The study group consisted of 108 patients; 25.9% with CB+.
- Delayed cerebral ischemia was diagnosed in 50% of CB+ and 23.8% of urine drug screen negative patients (P=0.01).
- CB+ was independently associated with development of delayed cerebral ischemia (odds ratio, 2.68; 95% confidence interval, 1.03-6.99; P=0.01).
- A significantly higher number of CB+ than urine drug screen negative patients had poor outcome (35.7% versus 13.8%; P=0.01).
- In univariate analysis, CB+ was associated with the composite end point of hospital mortality/severe disability (odds ratio, 2.93; 95% confidence interval, 1.07-8.01; P=0.04).
- However, after adjusting for other predictors, this effect was no longer significant.
No comments:
Post a Comment